Myriad Genetics, Inc.
Net Cash Flow Breakdown
Total Cash from Operations: $217.1M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $5.2M | 2.4% |
| Business Acquisitions | $80.9M | 37.3% |
| Stock Repurchases | $104.1M | 48.0% |
| Working Capital | $26.9M | 12.4% |
| Net Cash Flow | $0 | 0.0% |